Clinical trial
A Study in Adult and Pediatric Patients With Cystic Fibrosis
NCT00034515 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00034515 |
|---|---|
| Title | A Study in Adult and Pediatric Patients With Cystic Fibrosis |
| Official title | Ph 1b/2a Study to Assess Levels of INS37217 and Placebo Treatment With Maximum Tolerated Dose Administered by Inhalation Via the Pari LC Star Nebulizer in Adult and Pediatric CF Patients |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) Inhalation Solution |
| Enrollment | 63 |
| Start date | Jun 1, 2001 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Apr 30, 2002 |
| Last update posted | Feb 16, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: